Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Tegoprazan-Based Dual, Triple, and Quadruple Therapies as First-Line Regimens for Helicobacter Pylori Eradication: A Prospective Randomized Controlled Trial

NCT06977841 is registered in ClinicalTrials.gov with Zhongshan Hospital (Xiamen), Fudan University as lead sponsor.

NCT NCT06977841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06977841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Tegoprazan-Based Dual, Triple, and Quadruple Therapies as First-Line Regimens for Helicobacter Pylori Eradication: A Prospective Randomized Controlled Trial
Lead sponsor
Zhongshan Hospital (Xiamen), Fudan University
Phase
Not applicable
Overall status
Completed
Start date
June 10, 2025
Completion date
March 10, 2026
Enrollment
640 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse reaction, helicobacter pylori eradication